Can a glucose monitor boost diabetes education for newly diagnosed patients?

NCT ID NCT05676593

Terminated Disease control Sponsor: University Hospital, Montpellier Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether using a Freestyle Libre 2 continuous glucose monitor for 28 days, along with standard therapeutic education, helps people recently diagnosed with type 2 diabetes improve their blood sugar control. The trial enrolled 27 adults diagnosed within the past year. The main goal was to see if the monitor led to better HbA1c levels after 3 months compared to education alone.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Freestyle Libre 2 (continuous glucose monitor)
What this could lead to: If successful, this could show that using a continuous glucose monitor alongside standard education helps people with newly diagnosed type 2 diabetes better manage their blood sugar.
What could go wrong: This was a small, early study (27 participants) that was terminated, so results may be limited. The device only measures glucose and does not treat the disease directly.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ENDOCRINOLOGY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

endocrine system disorder type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ENDOCRINOLOGY TYPE 2 DIABETES

Contacts and locations

Locations

UHM Montpellier

Montpellier, 34090, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.